Month: September 2026

Allowed claims cover compositions and methods for preventing or mitigating stress-induced behavioral responses

SARASOTA, FLA., Sept. 18, 2026 (GLOBE NEWSWIRE) — Silo Pharma (Nasdaq: SILO) (“Silo” or “the Company”), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems with a wholly owned managed AI agent platform, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application covering its lead asset, SPC-15, a novel intranasal therapeutic targeting post-traumatic stress disorder (PTSD).

The invention, titled “Compositions and Methods for the Prevention of Stress-Induced Fear, Depressive-Like and Anxiety-Like Behavior,” is also covered by a corresponding patent issued by the Japan Patent Office earlier this year.

Silo’s Chief Executive Officer Eric Weisblum commented, “Securing U.S. patent protection for this invention is an important component of our strategy for SPC-15 as we advance the drug’s development for PTSD,” said Eric Weisblum, Chief Executive Officer of Silo Pharma. “The allowed application is directed to both composition and method claims related to our proprietary therapeutic approach to preventing or delaying behavioral responses associated with stress-induced behavioral responses.”

A Notice of Allowance indicates that the patent office has completed its examination and determined that the application meets the requirements for patentability and should be granted shortly.

Silo’s biopharmaceutical intellectual property portfolio currently holds numerous issued and allowed patents.

About Silo Pharma, Inc.

Silo Pharma is a diversified developmental-stage biopharmaceutical company with a therapeutic focus on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. The Company’s portfolio includes innovative programs such as SPC-15 for post-traumatic stress disorder (PTSD), SP-26 for fibromyalgia and chronic pain, and a preclinical asset targeting Alzheimer’s disease. Silo’s research is conducted in collaboration with leading universities and laboratories. silopharma.com

QwikAgents, Silo Pharma’s wholly owned artificial intelligence subsidiary, is a managed AI agent platform that delivers dedicated autonomous agents for research, content generation, scheduling, and workflow automation each running in a persistent environment with proprietary smart-routing across multiple AI models. The subsidiary reflects Silo’s strategy to expand into high-growth technology markets while continuing to advance its core biopharmaceutical pipeline. qwikagents.com

Forward Looking Statements

This news release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified using words “could”, “believe”, “anticipate”, “intend”, “estimate”, “expect”, “may”, “continue”, “predict”, “potential”, and similar expressions that are intended to identify forward-looking statements. Such statements involve known and unknown risks, uncertainties, and other factors that could cause the actual results of the Company to differ materially from the results expressed or implied by such statements, including statements about changes to anticipated sources of revenues, future economic and competitive conditions, difficulties in developing the Company’s technology platforms, retaining and expanding the Company’s customer base, fluctuations in consumer spending on the Company’s products and other factors. Accordingly, although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company disclaims any obligations to publicly update or release any revisions to the forward-looking information contained in this press release, whether as a result of new information, future events, or otherwise, after the date of this press release or to reflect the occurrence of unanticipated events except as required by law.

Contact

(800) 705-0120
investors@silopharma.com

Company builds expansion strategy around institutional payments and treasury services as global stablecoin market grows 48.9% and business payment activity accelerates

HONG KONG, Sept. 18, 2026 (GLOBE NEWSWIRE) — SOLOWIN HOLDINGS (Nasdaq: AXG) reported $28.05 million in revenue for the fiscal year ended March 31, 2026, approximately 895% above $2.82 million a year earlier. Stablecoin and fiat trading volume increased 395% to $1.04 billion, adding approximately $830 million in annual activity as the company develops its institutional digital-finance business.

AXG’s operating progress extended across its platforms. Client assets under administration increased 347% to $848.8 million, AX ONE processed $226 million in payment volume, and FERION completed 10 tokenization projects representing $52 million in value. AI infrastructure contributed approximately $22.2 million, or 79% of group revenue, while Digital Asset Tokens contributed approximately $5.6 million. The company recorded a $13.29 million net loss.

The results place AXG’s expansion against a substantial increase in global stablecoin adoption. Stablecoin market capitalization grew 48.9% during calendar 2025, adding $102.1 billion to reach $311 billion. AXG’s revenue increased nearly tenfold during its fiscal year; company revenue, trading activity and industry market capitalization are distinct measures with different reporting periods.

A concentrated market with emerging institutional alternatives.

Tether’s USDT and Circle’s USDC remain the dominant stablecoins. At June 2026, their respective market capitalizations of $184.4 billion and $73.5 billion represented approximately 84.5% of the $305.1 billion global stablecoin market. Separately, Tiger Research estimated in February 2026 that approximately 99% of stablecoin market capitalization was U.S. dollar-pegged, underscoring both demand for digital dollars and policy concerns surrounding domestic-currency sovereignty.

Regional payment activity is beginning to diversify. CoinDesk Research reports that USDT’s share of identified Asia-Pacific stablecoin payment volume declined from 98% at the beginning of 2025 to 91% in July 2026. The shift suggests growing participation by alternative stablecoins as institutions evaluate licensing, reserve transparency, custody and integration capabilities alongside liquidity.

Business payments create a measurable expansion opportunity

McKinsey and Artemis estimate that stablecoin payments reached $390 billion on an annualized basis using December 2025 activity, more than double the previous year’s level. Business-to-business payments accounted for approximately $226 billion, increasing 733% year over year.

Asia-originated payments represented approximately $245 billion, followed by $95 billion from North America and $50 billion from Europe. These flows provide a commercial foundation for institutional supplier payments, cross-border settlement, payroll and treasury management.

Inflation and transaction costs reinforce the demand for more efficient financial services. Annual inflation reached 33.5% in Argentina and 31.51% in Türkiye in August 2026, while the World Bank’s third-quarter 2025 benchmark placed the average cost of sending a $200 remittance at 6.36%. Such conditions can encourage demand for dollar access and lower-cost transfers, although a dollar peg does not eliminate U.S. inflation exposure.

From regulatory capability to recurring commercial activity

Following AX Coin Bahrain’s receipt of its full stablecoin issuer license in June 2026, AXG’s stated priorities include commercializing AXUSD and AXBHD, integrating banking and payment partners, and developing GCC–Asia and GCC–Africa payment corridors. Commercial milestones include live integrations, transacting institutional customers and payment-volume growth. Product launches remain subject to applicable approvals and operational readiness.

Ling Ngai Lok, Chairman and CEO of Solowin,

“First, the mechanics, because most people missed them. Monday’s vote wasn’t on the CLARITY Act itself. It was a cloture vote on the motion to proceed — a procedural gate that needs 60 senators just to open floor debate. It got 49, against 50. Every Republican but four voted yes; the Democrats who had negotiated the text for months voted no, over an ethics clause on politicians’ own crypto holdings. Nobody voted against the substance: a clear split of digital asset oversight between the SEC and the CFTC, with the CFTC taking digital commodities and the SEC keeping securities. That framework passed the House 294 to 134 and cleared Senate Banking 15 to 9. It’s still on the Senate calendar. The battle is not over.

I want to thank the people who did the work — Senator Lummis and the Banking and Agriculture committee staff, the House sponsors who moved it last year, and the teams at both commissions who have been drafting rules in parallel. More than a hundred amendments were absorbed to get this far. That effort isn’t wasted; it’s the base for the next attempt.

And here’s why I’m optimistic. Both commissions are moving regardless. The CFTC chairman said this week he’ll act under existing statutory authority. The SEC’s crypto rulemaking is open for comment until October 20. Stablecoins already have their federal law in GENIUS. So the U.S. market structure is being built right now, agency by agency, with Congress catching up.

Best of all, it’s happening in public. Imagine this had passed quietly, buried in a spending bill — most of the market would have learned about it a year late. Instead it’s the biggest story in finance this week. Every institution, treasury desk and family office is being forced to form a view on digital assets now. More attention brings more participants, more participants bring deeper liquidity, and liquidity is what turns crypto from a trade into a market.

AXG chose the license-first path early — central-bank oversight in Bahrain, the SFC framework in Hong Kong. When the U.S. rules land, we won’t be scrambling. We’ll be operating. Washington’s delay isn’t a threat to us. It’s runway.”

Media contact
Charlotte QI
ir@solowin.io 

Order covers unmanned aerial systems and associated support. A separate memorandum frames expanded cooperation, subject to definitive agreements and government approvals

• Limited procurement order received from the Ministry of Defence of the Islamic Republic of Pakistan for unmanned aerial systems and associated support.
• Order represents an expansion of Powerus’s international defense business.
• Separate memorandum of understanding frames expanded cooperation in unmanned and autonomous systems, subject to definitive agreements and government approvals.
• Powerus delegation received by the Chief of Army Staff at General Headquarters, Rawalpindi, per a statement issued by Inter-Services Public Relations.
• Powerus has entered into a definitive merger agreement with Aureus Greenway Holdings Inc. (Nasdaq: PUSA). The proposed merger remains subject to customary closing conditions.

ORLANDO, Fla. and WEST PALM BEACH, Fla., Sept. 18, 2026 (GLOBE NEWSWIRE) — Aureus Greenway Holdings Inc. (“AGH”) (Nasdaq: PUSA) and Autonomous Power Corporation, doing business as Powerus (“Powerus”), today jointly announced that it has received a limited procurement order from the Ministry of Defence of the Islamic Republic of Pakistan for unmanned aerial systems and associated support.

The order represents an expansion of Powerus’s international defense business. No other terms of the order have been disclosed.

Powerus has also signed a strategic memorandum of understanding with senior defense officials of the Islamic Republic of Pakistan. The memorandum establishes a framework for potential expanded cooperation in unmanned and autonomous defense technologies and provides a basis for the parties to explore additional areas of cooperation and potential future deployment of Powerus systems. The memorandum is not a definitive agreement, creates no purchase obligation, and does not obligate either party to proceed. Any program or procurement contemplated under the framework would be subject to definitive agreements and to all applicable United States laws and regulations and government approvals.

On September 16, 2026, a Powerus delegation led by Co-Founder Brett Velicovich was received by Field Marshal Syed Asim Munir, Chief of Army Staff and Chief of Defence Forces, at General Headquarters in Rawalpindi. In a statement issued by Inter-Services Public Relations, the media wing of the Pakistan Armed Forces, the meeting was described as covering matters of mutual interest, evolving trends in defence technology, and avenues for cooperation in defence procurement, production and capacity building. The statement said both sides expressed interest in further developing engagement in areas of mutual interest.

“This is an important milestone for Powerus as we expand our international defense footprint,” said Brett Velicovich, Co-Founder of Powerus. “We are proud to support Pakistan’s Ministry of Defence, and the memorandum gives both sides a strategic framework to build upon.”

“We are pleased to jointly announce this milestone with Powerus,” said Matthew Saker, Interim Chief Executive Officer of AGH. “The Ministry of Defence order and the strategic memorandum of understanding reflect the kind of international defense traction that we believe supports the strategic rationale for the pending combination.”

About POWERUS

Powerus (Autonomous Power Corporation) builds and scales unified autonomous systems designed to move, protect, and sustain critical assets in high-risk environments, with capabilities spanning heavy-lift platforms, autonomous air systems, autonomous maritime systems, mission systems, training and support, and U.S.-based manufacturing. Powerus previously announced a proposed merger with AGH (Nasdaq: PUSA); the merger has not closed and remains subject to the satisfaction of customary closing conditions and applicable regulatory approvals. Learn more at power.us.

ABOUT AUREUS GREENWAY HOLDINGS, INC.

Aureus Greenway Holdings Inc. (Nasdaq: PUSA) currently owns and operates golf course properties in Florida, including Kissimmee Bay Country Club and Remington Golf Club in the greater Orlando region. AGH has filed a registration statement on Form S-4 with the SEC, which includes an information statement and prospectus, in connection with its proposed business combination with Powerus. The registration statement was declared effective on August 12, 2026. Learn more at aureusgreenway.com.

Each of AGH and Powerus has provided the information herein relating to its own business, operations, financial condition, technology, products, certifications, contracts, and prospects. Neither party has independently verified the other party’s information, and each party disclaims any representation or warranty, express or implied, as to the accuracy, completeness, or reliability of the other party’s information.

PROPOSED MERGER

Powerus has previously announced a proposed merger with Aureus Greenway Holdings Inc. (Nasdaq: PUSA). Under the terms of the previously announced agreement, Powerus will merge with and into a newly formed subsidiary of AGH, with Powerus continuing as the surviving entity and AGH adopting the name “Powerus Corporation.” AGH has changed its Nasdaq ticker to PUSA in anticipation of its pending combination with Powerus, expected to close in Q4 2026, subject to customary closing conditions, including the effectiveness of a registration statement on Form S-4 (declared effective August 12, 2026) and receipt of required regulatory approvals. There can be no assurance that the proposed transactions will be consummated or as to the timing of any such consummation.

FORWARD-LOOKING STATEMENTS

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. As to the Pakistan Ministry of Defence order and the memorandum of understanding described in this release, these statements include, without limitation, statements regarding the scope and performance of the order; the memorandum of understanding and the prospect of expanded cooperation; anticipated demand for unmanned and autonomous defense systems; and the ability to obtain and maintain required export and regulatory authorizations. Forward-looking statements may be identified by terminology such as “may,” “will,” “should,” “targets,” “plans,” “intends,” “goal,” “anticipates,” “expects,” “believes,” “potential,” or “continue” or negatives of such terms or other comparable terminology. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially.

As to the proposed business combination between Powerus and AGH, these statements include, without limitation, statements regarding the proposed merger between Powerus and AGH; the anticipated benefits of the merger; the registration statement on Form S-4, the declaration of effectiveness by the SEC, and the SEC’s review process; the expected timing of the completion of the merger; the anticipated listing and trading of the combined company’s securities; future financial and operating results; the plans, objectives, expectations and intentions of either company or of the combined company following the merger; anticipated future results of either company or of the combined company following the merger; and the anticipated benefits and strategic and financial rationale of the merger and other statements that are not historical facts and its expected timing.

All forward-looking statements are subject to risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from any results expressed or implied by such forward-looking statements. As to the Pakistan Ministry of Defence order and the memorandum of understanding described in this release, such factors include, among others: (1) that the memorandum of understanding is not a definitive agreement, creates no purchase obligation, and does not obligate either party to proceed, and that any program or procurement contemplated under the framework would be subject to definitive agreements and to all applicable United States laws and regulations and government approvals; (2) that the order does not guarantee future orders, a continuing relationship, or additional procurement; (3) that required export licenses, authorizations, permits, or other governmental consents may be delayed, denied, suspended, revoked, or made subject to conditions; (4) political, security, regulatory, and economic conditions in Pakistan; (5) risks relating to production, delivery, and reliance on third-party suppliers; and (6) other Powerus-specific operational uncertainties.

As to the announced merger agreement, such factors include, among others: (1) the risk of delays in consummating the potential transaction, including as a result of required shareholder and regulatory approvals, including Nasdaq listing requirements which may not be obtained on the expected timeline, or at all; (2) the risk of any event, change or other circumstance that could give rise to the termination of the merger agreement; (3) the possibility that any of the anticipated benefits and projected synergies of the potential transactions will not be realized or will not be realized within the expected time period; (4) the limited operational history of Powerus as a combined organization and integration risks of acquired businesses; (5) diversion of management’s attention or disruption to the parties’ businesses as a result of the announcement and pendency of the transaction, including potential distraction of management from current plans and operations of AGH or Powerus and the ability of AGH or Powerus to retain and hire key personnel; (6) reputational risk and the reaction of each company’s customers, suppliers, employees or other business partners to the transaction; (7) the possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; (8) the outcome of any legal or regulatory proceedings that may be instituted against AGH or Powerus related to the merger agreement or the transaction; (9) the risks associated with third party contracts containing consent and/or other provisions that may be triggered by the proposed transaction; (10) legislative, regulatory, political, market, economic and other conditions, developments and uncertainties affecting AGH’s or Powerus’s businesses; (11) the evolving legal, regulatory, tax, and international trade regimes; (12) the nature, cost and outcome of potential litigation and other legal proceedings, including any such proceedings related to the transactions; (13) restrictions during the pendency of the proposed transaction that may impact AGH’s or Powerus’s ability to pursue certain business opportunities or strategic transactions; and (14) unpredictability and severity of catastrophic events, including, but not limited to, extreme weather, natural disasters, acts of terrorism or outbreak of war or hostilities, as well as AGH’s and Powerus’s response to any of the aforementioned factors.

In connection with the proposed merger, AGH has filed relevant materials with the SEC, including a registration statement on Form S-4, which includes an information statement and prospectus, and may file additional materials in the future. Investors and security holders are urged to read those materials because they contain important information. Forward-looking statements speak only as of the date of this release, and except as required by law, neither company undertakes any obligation to update them. This release does not constitute an offer to sell or the solicitation of an offer to buy any securities.

NO OFFER OR SOLICITATION

This document is for informational purposes only and is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.

IMPORTANT INFORMATION AND WHERE TO FIND IT

In connection with the transaction, AGH has filed a registration statement on Form S-4 with the SEC, which includes an information statement and prospectus of AGH, and has mailed a definitive information statement and prospectus to its stockholders. Investors and security holders are urged to read the registration statement (and any other documents filed with the SEC in connection with the transaction or incorporated by reference into the registration statement) because such documents contain important information regarding the proposed transaction and related matters. Investors and security holders may obtain free copies of these documents and other documents filed with the SEC by AGH through the website maintained by the SEC at http://www.sec.gov or at AGH’s website at https://www.aureusgreenway.com/secfilings.

AGH has not independently verified and makes no representation or warranty, express or implied, as to the accuracy, completeness, or reliability of the information in this release relating to the business, operations, financial condition, technology, products, certifications, contracts, or prospects of Powerus or its subsidiaries. Such information has been provided by Powerus, and AGH disclaims any obligation to update or correct such information.

CONTACTS

AGH Investor Relations
Jason Assad
678-570-6791

Powerus Press Contact
Escalate PR
pr@power.us

Year-to-date bookings of $16.2 million include a combination of fit-for-purpose multi-modal datasets, datasets-plus-license arrangements, and multi-year platform access licenses; a significant portion of these bookings are expected to be delivered during the remainder of the year

MINNEAPOLIS, Sept. 18, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced year-to-date bookings of approximately $16.2 million, a 16X increase versus the same period in 2025. A significant portion of these bookings are expected to be delivered during the remainder of the year.

Approximately 50% of the contracts booked during 2026 are with new customers to OneMedNet, while the existing customer base continues to expand their business with the Company through high rates of reorder and follow-on engagement.

Platform improvements have increased OneMedNet’s order-fulfillment speed by approximately 50X, accelerating how quickly the Company can assemble, qualify, and deliver fit-for-purpose multi-modal datasets. This increase in speed allows the Company to take on large orders while providing quick delivery to meet our customers’ project schedules.

Life sciences, medical device, and AI organizations continue to use OneMedNet’s iRWD™ Platform for regulatory submissions, foundation-model development, cohort discovery, feasibility studies, and high-value research, which is reflected in our bookings backlog. This builds on our network of more than 2,300 healthcare partner sites and more than 90 million patient journeys and 270 million studies.

Key Highlights

• Contracted demand: Approximately $16.2 million in year-to-date bookings, a 16X increase over the same period in 2025.
• Growth from new and existing customers: Approximately 50% of contracts booked during 2026 are with new customers to OneMedNet, complemented by reorder and expansion activity from existing customers.
• Faster fulfillment: Order fulfillment is approximately 50X faster, which allows the Company to take on larger orders and deliver faster.

“Our commercial engine is delivering,” said Aaron Green, CEO & President. “Bookings are up more than 16X year over year, and we are executing to our contracted delivery schedules. Expanding demand combined with disciplined execution is what builds durable value. The market is shifting decisively towards direct-from-source, regulatory grade Real-World Data, and OneMedNet through our provider network and advanced technology is positioned to deliver it at the speed, scale, and quality that modern healthcare innovation demands.”

About OneMedNet Corporation

OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the potential of more than 2,300 healthcare sites through its iRWD™ platform. This is not just data — it is the foundation of innovation, from de-identified medical imaging to electronic health records, fueling work for drugmakers, medical device companies, and AI developers. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that support patient care and the next wave of healthcare innovation.

Learn more at www.onemednet.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release are forward-looking statements. These statements include, but are not limited to, statements regarding demand for our products and services, the composition and durability of our customer base, the speed of order fulfillment, the acceptance of our delivered data sets allowing for the conversion of bookings to revenue, our ability to achieve our operational strategies, our expected growth in the business, and statements generally about our products, plans and strategies.

Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include, but are not limited to: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; the timing of customer acceptance and data delivery; and the other risks described in our most recent Annual Report on Form 10-K and our subsequent filings with the Securities and Exchange Commission. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

OneMedNet Contacts:
Michael Wong, VP Marketing
Email: michael.wong@onemednet.com

WEST DES MOINES, Iowa and NEW YORK, Sept. 18, 2026 (GLOBE NEWSWIRE) — Athene Holding Ltd (“Athene”) and Imran Siddiqui today jointly announce that they have resolved the legal proceedings commenced by Athene against Mr. Siddiqui and Caldera Holdings Limited in May 2018 in the Supreme Court of Bermuda. As part of this resolution, Mr. Siddiqui agreed to make the following statement:

“Athene has compromised its claim with Mr Siddiqui and Caldera Holdings Limited. The terms of settlement are confidential.

However, Mr Siddiqui has agreed as part of that agreement to acknowledge that in 2016 and 2017, he sent and received documents which contained information which was confidential to Athene in connection with the establishment of Caldera, a competitive company he was trying to set up.

Mr Siddiqui acknowledges that, in behaving in this way, he breached fiduciary duties which he owed to Athene. Mr Siddiqui did not think that at the time, but on reflection he now acknowledges that he should have known that sending and receiving the documents that he did was a breach of his obligations.”

The parties will not comment further on this matter.

CONTACT: Contact:
externalrelations@athene.com

WEST DES MOINES, Iowa, Sept. 18, 2026 (GLOBE NEWSWIRE) — West Bancorporation, Inc. (Nasdaq: WTBA) (the “Company”), parent company of West Bank, will report its results for the third quarter of 2026 on Thursday, October 29, 2026 before the markets open.

The Company will discuss its results in a conference call scheduled for 2:00 p.m. Central Time on Thursday, October 29, 2026. The telephone number for the conference call is 833-461-5787. The meeting ID for the conference call is 761930850. A recording of the call will be available until November 12, 2026, by dialing 833-309-1852. The meeting ID for the replay call is 761930850.

West Bancorporation, Inc. is headquartered in West Des Moines, Iowa. Serving its customers since 1893, West Bank, a wholly-owned subsidiary of West Bancorporation, Inc., is a community bank that focuses on lending, deposit services and trust services for consumers and small- to medium-sized businesses. The Bank has six offices in the greater Des Moines, Iowa area, one office in Coralville, Iowa, and four offices in Minnesota, in the cities of Rochester, Mankato, Owatonna and St. Cloud.

For more information contact:
Jane Funk, Executive Vice President, Treasurer and Chief Financial Officer (515) 222-5766